Diphtheria tetanus pertussis containing vaccines update
Updated information on market demand and supply trends for diphtheria, tetanus, and pertussis-containing vaccines procured by UNICEF.
Highlights
This note's latest release provides an update on diphtheria, tetanus, and pertussis-containing vaccines, including pentavalent (DTwP-HepB-Hib) and hexavalent (DTwP-HepB-IPV-Hib) vaccines. It includes demand and supply market developments, including the differences between forecasted and actual and projected procurement for the 2023-2025 period.
The document highlights that demand for the pentavalent vaccine experienced a surge due to diphtheria outbreaks and “The Big Catch-Up”, a targeted global effort by WHO, UNICEF, Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation to boost vaccination among children following declines driven by the COVID-19 pandemic. In contrast, demand for hexavalent vaccine materialized slower than expected. This note also highlights the interconnected market dynamics of these vaccines as well as overall market health considerations.
An 2023 version of this note is also available for download.
